Barrons' Johanna Bennett recommended a few pharmaceutical ETFs for investors looking to get exposure to the industry. The S&P Pharmacuetical index rose 24 percent since the beginning of the year, Bennett pointed out.

She suggested investors take a look at BlackRock [profile] iShares US Healthcare ETF and Elect Sector Health Care Select Sector SPDR Fund, State Street Bank & Trust [profile] SPDR S&P Pharmaceuticals ETF, Invesco [profile] PowerShares Dynamic Pharmaceuticals Portfolio and iShares US Pharmaceuticals ETF.

Bond investors are turning to ultra-short-term bond ETFs now that interest rates are going up, Barrons' Chris Dieterich writes. Vanguard [profile] Short-term Bond, which raked in $3.7 billion brought in the most bond ETF flows and iShares Short Treasury Bond ETF doubled in size so far this year, Dieterich reports.

To read more, click here and here. 

Edited by: Casey Quinlan


Stay ahead of the news ... Sign up for our email alerts now
CLICK HERE